Reserach Projects
Ariel Wang
MSc, PhD
Senior Statistician
I am a senior statistician in the hypertension team. My research interests include methodology studies, diagnostic studies, risk prediction models, big data, and trials (including RCTs). I work on the STRAtifying Treatments In the multi-morbid Frail elderlY (STRATIFY) project, where we develop prediction models to understand an individual’s risk of specific adverse events associated with antihypertensive treatment, and the OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE) project, which investigates whether and to what extent blood pressure medications can be safely reduced in poly-antihypertensives-medicated older patients. Currently, I lead the SPCR-funded methodology study Agreement of data Generated from Routine Electronic hEalth records across primary and secondary care and a randomised controlled trial (AGREE), which aims to provide reliable evidence pertaining to data accuracy.
Before joining the PHC, I worked as a medical statistician in the Centre for Statistics in Medicine and Oxford Clinical Trial Research Unit in NDORMS. I contributed statistical expertise to the statistical analysis and reporting of trials across a range of clinical areas including diagnostic study, cancer, trauma, rehabilitation, surgical trials, as well as drug trials.
I hold a PhD in Health Sciences. My PhD research focused on the epidemiology of mental well-being in later life and explored various aspects of mental well-being, including its distribution, determinants, and consequences.
Recent publications
-
Journal article
Versluis J. et al, (2024), J Clin Oncol
-
Journal article
Sheppard JP. et al, (2024), The Lancet Healthy Longevity, 5, e563 - e573
-
Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
Journal article
SHEPPARD J. et al, (2024), The Lancet Healthy Longevity
-
Journal article
Sheppard J. et al, (2024), Journal of Hypertension, 42, e109 - e110
-
PREDITING THE RISK OF FRACTURE ASSOCIATED WITH ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT OF THE STRATIFY-FRACTURE PREDICTION MODEL
Conference paper
Wang A. et al, (2023), JOURNAL OF HYPERTENSION, 41, E3 - E3